SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001683168-23-008503
Filing Date
2023-11-28
Accepted
2023-11-28 17:06:22
Documents
1
Period of Report
2023-11-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4671
  Complete submission text file 0001683168-23-008503.txt   6519
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Reporting) CIK: 0001157075 (see all company filings)

State of Incorp.: NV | Fiscal Year End: 0430
Type: 3 | Act: 34 | File No.: 001-40492 | Film No.: 231447395
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3950 JOHNS CREEK COURT SUITE 100 SUWANEE GA 30024
Business Address 3950 JOHNS CREEK COURT SUITE 100 SUWANEE GA 30024 770-500-3910
FEMASYS INC (Issuer) CIK: 0001339005 (see all company filings)

IRS No.: 113713499 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus